Involvement of endoplasmic reticulum stress in homocysteine-induced apoptosis of osteoblastic cells

Journal of Bone and Mineral Metabolism

Volumn 30, Issue 4, 2012, Pages 474-484

  Park, Su Jung ^a   Kim, Ki Jo ^a   Kim, Wan Uk ^a   Oh, Il Hoan ^a   Cho, Chul Soo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Endoplasmic reticulum stress; Homocysteine; Osteoblast; Osteoporosis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; BINDING PROTEIN; CASPASE 3; CASPASE 3 INHIBITOR; CCAAT ENHANCER BINDING PROTEIN; CYTOCHROME C; ENDONUCLEASE; GLUCOSE REGULATED PROTEIN 78; HOMOCYSTEINE; INOSITOL REQUIRING TRANSMEMBRANE KINASE AND ENDONUCLEASE 1ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE SILENCING; HUMAN; HUMAN CELL; MITOCHONDRION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CASPASE 3; CASPASE INHIBITORS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; ENDOPLASMIC RETICULUM STRESS; ENDORIBONUCLEASES; GENE SILENCING; HOMOCYSTEINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERHOMOCYSTEINEMIA; MOLECULAR TARGETED THERAPY; ORGAN SPECIFICITY; OSTEOARTHRITIS, KNEE; OSTEOBLASTS; OSTEOPOROSIS; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE;

EID: 84863883139     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-011-0346-9     Document Type: Article

References (52)

1. Kanis JA, McCloskey EV, Johansson H, Oden A (2009) Approaches to the targeting of treatment for osteoporosis. Nat Rev Rheumatol 5:425-431
2. Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850
3. Manolagas SC (1998) Cellular and molecular mechanisms of osteoporosis. Aging (Milano) 10:182-190
4. Weinstein RS, Manolagas SC (2000) Apoptosis and osteoporosis. Am J Med 108:153-164 (Pubitemid 30064426)
5. Harvey N, Dennison E, Cooper C (2010) Osteoporosis: impact on health and economics. Nat Rev Rheumatol 6:99-105
6. Levasseur R (2009) Bone tissue and hyperhomocysteinemia. Jt Bone Spine 76:234-240
7. Yap S, Naughten E (1998) Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis 21:738-747 (Pubitemid 28477146)
8. Testai FD, Gorelick PB (2010) Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders. Arch Neurol 67:148-153
9. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM et al (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033-2041
10. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042-2049 (Pubitemid 38596555)
11. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS (2007) Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study. J Bone Miner Res 22:747-756 (Pubitemid 351339104)
12. Herrmann M, Wildemann B, Claes L, Klohs S, Ohnmacht M, Taban-Shomal O, Hubner U, Pexa A, Umanskaya N, Herrmann W (2007) Experimental hyperhomocysteinemia reduces bone quality in rats. Clin Chem 53:1455-1461 (Pubitemid 47206341)
13. Gupta S, Kuhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A, High KA, Austin RC, Kruger WD (2009) Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J 23:883-893
14. Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros VG, Mikhailidis DP (2009) Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int 20:197-207
15. Zhang K, Kaufman RJ (2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454:455-462
16. Ji C, Kaplowitz N (2003) Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124:1488-1499 (Pubitemid 36531821)
17. Kim HJ, Cho HK, Kwon YH (2008) Synergistic induction of ER stress by homocysteine and beta-amyloid in SH-SY5Y cells. J Nutr Biochem 19:754-761
18. Chigurupati S, Wei Z, Belal C, Vandermey M, Kyriazis GA, Arumugam TV, Chan SL (2009) The homocysteine-inducible endoplasmic reticulum stress protein counteracts calcium store depletion and induction of CCAAT enhancer-binding protein homologous protein in a neurotoxin model of Parkinson disease. J Biol Chem 284:18323-18333
19. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, Kitajima S (2001) Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276:35867-35874
20. Shirakawa K, Maeda S, Gotoh T et al (2006) CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation. Mol Cell Biol 26:6105-6116 (Pubitemid 44204529)
21. Pereira RC, Stadmeyer LE, Smith DL, Rydziel S, Canalis E (2007) CCAAT/enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia. Bone 40:619-626 (Pubitemid 46187217)
22. Yoo SA, Park BH, Park GS, Koh HS, Lee MS, Ryu SH, Miyazawa K, Park SH, Cho CS, Kim WU (2006) Calcineurin is expressed and plays a critical role in inflammatory arthritis. J Immunol 177:2681-2690 (Pubitemid 44201027)
23. Lee SJ, Kim KM, Namkoong S et al (2005) Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 280:5781-5788 (Pubitemid 40280058)
24. Yuan Q, Jiang DJ, Chen QQ, Wang S, Xin HY, Deng HW, Li YJ (2007) Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells. Biochem Biophys Res Commun 356:880-885 (Pubitemid 46529375)
25. Kim DJ, Koh JM, Lee O, Kim NJ, Lee YS, Kim YS, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 39:582-590 (Pubitemid 44149276)
26. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link.Nat RevMol Cell Biol 4:552-565 (Pubitemid 36773407)
27. Degli Esposti M (2004) Mitochondria in apoptosis: past, present and future. Biochem Soc Trans 32:493-495
28. Cotter TG (2009) Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 9:501-507
29. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776
30. Althausen S, Paschen W (2000) Homocysteine-induced changes in mRNA levels of genes coding for cytoplasmic- and endoplasmic reticulum-resident stress proteins in neuronal cell cultures. Brain Res Mol Brain Res 84:32-40
31. Shen X, Ellis RE, Lee K et al (2001) Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 107:893-903 (Pubitemid 34084980)
32. Cox JS, Shamu CE, Walter P (1993) Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 73:1197-1206 (Pubitemid 23180493)
33. Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL (2003) Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278:50259-50272 (Pubitemid 37548867)
34. Tsuboi M, Kawakami A, Nakashima T et al (1999) Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med 134:222-231 (Pubitemid 29423094)
35. Suhara T, Fukuo K, Yasuda O, Tsubakimoto M, Takemura Y, Kawamoto H, Yokoi T, Mogi M, Kaimoto T, Ogihara T (2004) Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension 43:1208-1213 (Pubitemid 38696913)
36. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880-885 (Pubitemid 44523966)
37. Zhang K, Kaufman RJ (2006) The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66:S102-S109 (Pubitemid 43739994)
38. Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y (2002) An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 277:34287-34294
39. Cai Y, Zhang C, Nawa T, Aso T, Tanaka M, Oshiro S, Ichijo H, Kitajima S (2000) Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood 96:2140-2148
40. Zhang C, Kawauchi J, Adachi MT, Hashimoto Y, Oshiro S, Aso T, Kitajima S (2001) Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun 289:718-724 (Pubitemid 33152292)
41. Chen YR, Meyer CF, Tan TH (1996) Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem 271:631-634
42. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-529 (Pubitemid 46985379)
43. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982-995 (Pubitemid 28204605)
44. Yang X, Matsuda K, Bialek P et al (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 117:387-398 (Pubitemid 38534544)
45. Zhang P, McGrath B, Li S, Frank A, Zambito F, Reinert J, Gannon M, Ma K, McNaughton K, Cavener DR (2002) The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol 22:3864-3874 (Pubitemid 34525227)
46. Lisse TS, Thiele F, Fuchs H et al (2008) ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet 4:e7
47. Berglund S, Sodergren A, Wallberg Jonsson S, Rantapaa Dahlqvist S (2009) Atherothrombotic events in rheumatoid arthritis are predicted by homocysteine - a six-year follow-up study. Clin Exp Rheumatol 27:822-825
48. Lazzerini PE, Selvi E, Lorenzini S, Capecchi PL, Ghittoni R, Bisogno S, Catenaccio M, Marcolongo R, Galeazzi M, Laghi-Pasini F (2006) Homocysteine enhances cytokine production in cultured synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 24:387-393 (Pubitemid 44363539)
49. Kokame K, Kato H, Miyata T (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J Biol Chem 271:29659-29665 (Pubitemid 26389590)
50. Blass S, Union A, Raymackers J, Schumann F, Ungethum U, Muller-Steinbach S, De Keyser F, Engel JM, Burmester GR (2001) The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum 44:761-771 (Pubitemid 32319768)
51. Hampton RY (2002) ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 14:476-482
52. Amano T, Yamasaki S, Yagishita N et al (2003) Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev 17:2436-2449 (Pubitemid 37214791)